---
figid: PMC3572712__nihms433615f1
figlink: /pmc/articles/PMC3572712/figure/F1/
number: F1
caption: Arachidonic acid, a constituent of cell membrane lipid domains is released
  by phospholipases, especially a cytosolic phospholipase (PL)A2, mobilized by physical
  and chemical stimuli, and is subject to metabolism by prostaglandin (PG) G/H synthases
  to form sequentially PG endoperoxides, PGG2 and PGH2. The latter is then subject
  to further metabolism by synthases and isomerases to form thromboxane (Tx)A2 and
  PGs, each of which activates G protein coupled receptors termed T,E,D, I of F prostanoid
  (P) receptors. Cells typically make one or two dominant PGs. Besides DP1, PGD2 also
  activates at low concentrations a member of the fMPL receptor superfamily, termed
  CRTH2 or colloquially, DP2. VSMCs denotes vascular smooth muscle cells. Reproduced
  with permission from Ricciotti E & FitzGerald GA., ATVB 2011;31:986–1000.
pmcid: PMC3572712
papertitle: 'Historical Lessons in Translational Medicine: Cyclooxygenase Inhibition
  and P2Y12 Antagonism.'
reftext: Desmond J. Fitzgerald, et al. Circ Res. ;112(1):174-194.
pmc_ranked_result_index: '86532'
pathway_score: 0.8920558
filename: nihms433615f1.jpg
figtitle: 'Historical Lessons in Translational Medicine: Cyclooxygenase Inhibition
  and P2Y12 Antagonism'
year: ''
organisms:
- Homo sapiens
ndex: c2bc4dab-dea2-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3572712__nihms433615f1.html
  '@type': Dataset
  description: Arachidonic acid, a constituent of cell membrane lipid domains is released
    by phospholipases, especially a cytosolic phospholipase (PL)A2, mobilized by physical
    and chemical stimuli, and is subject to metabolism by prostaglandin (PG) G/H synthases
    to form sequentially PG endoperoxides, PGG2 and PGH2. The latter is then subject
    to further metabolism by synthases and isomerases to form thromboxane (Tx)A2 and
    PGs, each of which activates G protein coupled receptors termed T,E,D, I of F
    prostanoid (P) receptors. Cells typically make one or two dominant PGs. Besides
    DP1, PGD2 also activates at low concentrations a member of the fMPL receptor superfamily,
    termed CRTH2 or colloquially, DP2. VSMCs denotes vascular smooth muscle cells.
    Reproduced with permission from Ricciotti E & FitzGerald GA., ATVB 2011;31:986–1000.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - DLK1
  - PLA2G7
  - PLA2G10
  - PLA2G2F
  - PGF
  - PLA2G6
  - PLA2G5
  - HPGDS
  - TFDP1
  - PLA2G2E
  - PTGER3
  - PLA2G4A
  - PLA2G3
  - PLA2G1B
  - PLA2G12A
  - PTGDR2
  - PLA2G12B
  - PLA2G4C
  - PTGER1
  - PTGER4
  - PLA2G2C
  - PLA2G2D
  - PLA2G4D
  - PLA2G2A
  - PGE2
genes:
- word: PG|2
  symbol: pG2
  source: hgnc_alias_symbol
  hgnc_symbol: DLK1
  entrez: '8788'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G7
  entrez: '7941'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G10
  entrez: '8399'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G2F
  entrez: '64600'
- word: PGF
  symbol: PGF
  source: hgnc_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: IPLA2
  symbol: iPLA2
  source: hgnc_alias_symbol
  hgnc_symbol: PLA2G6
  entrez: '8398'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G5
  entrez: '5322'
- word: PGD2
  symbol: PGD2
  source: hgnc_alias_symbol
  hgnc_symbol: HPGDS
  entrez: '27306'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G6
  entrez: '8398'
- word: DP1,
  symbol: Dp-1
  source: hgnc_alias_symbol
  hgnc_symbol: TFDP1
  entrez: '7027'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G2E
  entrez: '30814'
- word: EP3*,
  symbol: EP3
  source: hgnc_alias_symbol
  hgnc_symbol: PTGER3
  entrez: '5733'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G4A
  entrez: '5321'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G3
  entrez: '50487'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G1B
  entrez: '5319'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G12A
  entrez: '81579'
- word: CRTH2
  symbol: CRTH2
  source: hgnc_alias_symbol
  hgnc_symbol: PTGDR2
  entrez: '11251'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G12B
  entrez: '84647'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G4C
  entrez: '8605'
- word: EP1,
  symbol: EP1
  source: hgnc_alias_symbol
  hgnc_symbol: PTGER1
  entrez: '5731'
- word: EP1,EP2,EP3*,EP4
  symbol: EP4
  source: hgnc_alias_symbol
  hgnc_symbol: PTGER4
  entrez: '5734'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G2C
  entrez: '391013'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G2D
  entrez: '26279'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G4D
  entrez: '283748'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G2A
  entrez: '5320'
chemicals:
- word: PGE2
  source: MESH
  identifier: D015232
diseases: []
figid_alias: PMC3572712__F1
redirect_from: /figures/PMC3572712__F1
figtype: Figure
---
